![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TNS1 |
Gene summary for TNS1 |
![]() |
Gene information | Species | Human | Gene symbol | TNS1 | Gene ID | 7145 |
Gene name | tensin 1 | |
Gene Alias | MST091 | |
Cytomap | 2q35 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | B7Z6H8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7145 | TNS1 | NAFLD1 | Human | Liver | NAFLD | 2.41e-08 | 8.91e-01 | -0.04 |
7145 | TNS1 | S43 | Human | Liver | Cirrhotic | 3.07e-17 | 2.12e-01 | -0.0187 |
7145 | TNS1 | HCC1_Meng | Human | Liver | HCC | 4.43e-13 | -2.65e-01 | 0.0246 |
7145 | TNS1 | HCC2_Meng | Human | Liver | HCC | 1.76e-06 | -2.50e-01 | 0.0107 |
7145 | TNS1 | cirrhotic3 | Human | Liver | Cirrhotic | 1.86e-02 | 7.84e-04 | 0.0215 |
7145 | TNS1 | HCC2 | Human | Liver | HCC | 6.71e-06 | 2.72e+00 | 0.5341 |
7145 | TNS1 | HCC5 | Human | Liver | HCC | 1.15e-05 | -2.14e-01 | 0.4932 |
7145 | TNS1 | Pt13.b | Human | Liver | HCC | 8.86e-06 | 5.27e-02 | 0.0251 |
7145 | TNS1 | 047563_1562-all-cells | Human | Prostate | BPH | 6.34e-07 | 1.47e-01 | 0.0791 |
7145 | TNS1 | 048752_1579-all-cells | Human | Prostate | BPH | 1.20e-02 | 2.03e-01 | 0.1008 |
7145 | TNS1 | 052095_1628-all-cells | Human | Prostate | BPH | 2.20e-10 | 4.58e-01 | 0.1032 |
7145 | TNS1 | 052097_1595-all-cells | Human | Prostate | BPH | 5.92e-09 | 4.10e-01 | 0.0972 |
7145 | TNS1 | 052099_1652-all-cells | Human | Prostate | BPH | 3.54e-04 | 2.65e-01 | 0.1038 |
7145 | TNS1 | Dong_P1 | Human | Prostate | Tumor | 1.59e-14 | 4.98e-02 | 0.035 |
7145 | TNS1 | Dong_P3 | Human | Prostate | Tumor | 1.24e-17 | 1.19e-01 | 0.0278 |
7145 | TNS1 | Dong_P4 | Human | Prostate | Tumor | 1.39e-06 | 1.27e-01 | 0.0292 |
7145 | TNS1 | P7 | Human | Prostate | Tumor | 3.80e-03 | 5.79e-01 | -0.1025 |
7145 | TNS1 | GSM5353221_PA_PB2A_Pool_1_3_S25_L001 | Human | Prostate | Tumor | 1.38e-15 | 8.42e-01 | 0.1633 |
7145 | TNS1 | GSM5353222_PA_PB2B_Pool_1_3_S52_L002 | Human | Prostate | Tumor | 2.21e-21 | 9.19e-01 | 0.1608 |
7145 | TNS1 | GSM5353223_PA_PB2B_Pool_2_S26_L001 | Human | Prostate | Tumor | 1.15e-10 | 8.16e-01 | 0.1604 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TNS1 | insertion | In_Frame_Ins | novel | c.2854_2855insTCTGGTCCTCTCGTCCGCTTC | p.Ala952delinsValTrpSerSerArgProLeuPro | p.A952delinsVWSSRPLP | Q9HBL0 | protein_coding | TCGA-AX-A06J-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | SD | ||
TNS1 | deletion | Frame_Shift_Del | c.1409delG | p.Gly470AlafsTer23 | p.G470Afs*23 | Q9HBL0 | protein_coding | TCGA-B5-A11H-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Hormone Therapy | megace | SD | |||
TNS1 | deletion | Frame_Shift_Del | novel | c.1179delN | p.Asn394ThrfsTer9 | p.N394Tfs*9 | Q9HBL0 | protein_coding | TCGA-BG-A0VZ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | CR | ||
TNS1 | insertion | Frame_Shift_Ins | novel | c.4274_4275insG | p.Ser1426GlnfsTer27 | p.S1426Qfs*27 | Q9HBL0 | protein_coding | TCGA-DF-A2KY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD | ||
TNS1 | SNV | Missense_Mutation | c.706N>G | p.Ile236Val | p.I236V | Q9HBL0 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-CC-A7IH-01 | Liver | liver hepatocellular carcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | |
TNS1 | SNV | Missense_Mutation | novel | c.1090N>T | p.Ser364Cys | p.S364C | Q9HBL0 | protein_coding | deleterious(0) | possibly_damaging(0.614) | TCGA-DD-AAVV-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
TNS1 | SNV | Missense_Mutation | c.1828N>T | p.Ala610Ser | p.A610S | Q9HBL0 | protein_coding | tolerated(0.43) | benign(0) | TCGA-UB-A7MB-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Targeted Molecular therapy | sorafenib | PD | |
TNS1 | SNV | Missense_Mutation | novel | c.3022N>A | p.Glu1008Lys | p.E1008K | Q9HBL0 | protein_coding | tolerated(0.24) | benign(0.01) | TCGA-05-4424-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Targeted Molecular therapy | erlotinib | SD |
TNS1 | SNV | Missense_Mutation | rs200755457 | c.1735C>T | p.Arg579Trp | p.R579W | Q9HBL0 | protein_coding | deleterious(0.02) | possibly_damaging(0.745) | TCGA-44-6779-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | taxol | PD |
TNS1 | SNV | Missense_Mutation | c.5070N>G | p.Phe1690Leu | p.F1690L | Q9HBL0 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-44-A479-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |